BLND - Blend Labs, Inc.
NYSE
->
Technology
->
Software—Application
San Francisco,
United States
Type: Equity
BLND price evolution
BLND
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $55.04 | $45.45 | $84.52 | $30.96 |
| Short term investments | $67.15 | $43.5 | $105.96 | |
| Net receivables | $19.06 | $19.6 | $18.18 | $18.34 |
| Inventory | ||||
| Total current assets | $146.4 | $142.52 | $159.53 | $169.84 |
| Long term investments | $7.29 | $7.29 | $7.29 | |
| Property, plant & equipment | $11.44 | $15.13 | $14.34 | $12.51 |
| Goodwill & intangible assets | $2.1 | $2.1 | $2.11 | |
| Total noncurrent assets | $42.89 | $42.23 | $36.23 | |
| Total investments | $74.45 | $50.8 | $113.25 | |
| Total assets | $186.13 | $185.41 | $201.76 | $206.06 |
| Current liabilities | ||||
| Accounts payable | $1.86 | $1.08 | $1.9 | $2.17 |
| Deferred revenue | $20.83 | $21.54 | $8.98 | |
| Short long term debt | ||||
| Total current liabilities | $45.24 | $41.52 | $42.56 | $31.57 |
| Long term debt | $5.17 | $145.25 | $145.32 | |
| Total noncurrent liabilities | $6.74 | $147.31 | $147.54 | |
| Total debt | $5.17 | $145.25 | $145.32 | |
| Total liabilities | $98.24 | $48.27 | $189.87 | $179.12 |
| Shareholders' equity | ||||
| Retained earnings | -$1384.15 | -$1381.7 | -$1362.3 | -$1341.63 |
| Other shareholder equity | $0.77 | $0.3 | $0.35 | $0.44 |
| Total shareholder equity | -$45.47 | -$35.76 | -$19.24 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $30.96 | $124.2 | $213.08 | $41.27 |
| Short term investments | $105.96 | $229.95 | $334.15 | $110.63 |
| Net receivables | $18.34 | $23.97 | $39.44 | $14.98 |
| Inventory | ||||
| Total current assets | $169.84 | $396.1 | $613.02 | $186.15 |
| Long term investments | $7.29 | $5.36 | $5.36 | $5.02 |
| Property, plant & equipment | $12.51 | $17.41 | $20.87 | $17.28 |
| Goodwill & intangible assets | $2.11 | $2.13 | $460.24 | $1.21 |
| Total noncurrent assets | $36.23 | $36.67 | $499.47 | $29.6 |
| Total investments | $113.25 | $235.31 | $339.5 | $115.65 |
| Total assets | $206.06 | $432.76 | $1112.49 | $215.75 |
| Current liabilities | ||||
| Accounts payable | $2.17 | $1.26 | $6.16 | $3.44 |
| Deferred revenue | $8.98 | $8.7 | $8.07 | $13.62 |
| Short long term debt | ||||
| Total current liabilities | $31.57 | $35.47 | $60.03 | $35.03 |
| Long term debt | $145.32 | $216.8 | $213.84 | $14 |
| Total noncurrent liabilities | $147.54 | $233.37 | $241.87 | $17.38 |
| Total debt | $145.32 | $227.89 | $228.45 | $14 |
| Total liabilities | $179.12 | $309.59 | $337.84 | $52.41 |
| Shareholders' equity | ||||
| Retained earnings | -$1341.63 | -$1162.94 | -$442.76 | -$272.85 |
| Other shareholder equity | $0.44 | -$0.71 | -$0.81 | -$0.01 |
| Total shareholder equity | -$19.24 | $123.17 | $774.64 | $163.34 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $45.18 | $40.48 | $34.95 | $36.1 |
| Cost of revenue | $18.8 | $16.81 | $16.38 | |
| Gross Profit | $26 | $21.68 | $18.14 | $19.73 |
| Operating activities | ||||
| Research & development | $12.92 | $14.18 | $14.42 | |
| Selling, general & administrative | $21.89 | $24.15 | $26.48 | |
| Total operating expenses | $33.15 | $35.02 | $39.32 | $41.59 |
| Operating income | -$13.34 | -$21.18 | -$21.87 | |
| Income from continuing operations | ||||
| EBIT | -$17.74 | -$15.53 | -$23.27 | |
| Income tax expense | $0.02 | $0.02 | $0.04 | -$0.07 |
| Interest expense | $1.65 | $5.1 | $7.08 | |
| Net income | ||||
| Net income | -$8.25 | -$19.41 | -$20.67 | -$30.29 |
| Income (for common shares) | -$23.59 | -$22.13 | -$31.81 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $156.85 | $235.2 | $234.5 | $96.03 |
| Cost of revenue | $75.71 | $145.55 | $118.51 | $34.29 |
| Gross Profit | $81.14 | $89.65 | $115.99 | $61.74 |
| Operating activities | ||||
| Research & development | $81.59 | $138.09 | $92.22 | $55.5 |
| Selling, general & administrative | $130.82 | $224.37 | $212.88 | $81.53 |
| Total operating expenses | $237.36 | $835.83 | $313.23 | $137.03 |
| Operating income | -$156.22 | -$746.18 | -$197.24 | -$75.29 |
| Income from continuing operations | ||||
| EBIT | -$147.79 | -$697.62 | -$197.52 | -$74.59 |
| Income tax expense | $0.09 | -$2.24 | -$38.89 | $0.03 |
| Interest expense | $30.81 | $24.79 | $11.28 | |
| Net income | ||||
| Net income | -$178.69 | -$720.17 | -$169.91 | -$74.62 |
| Income (for common shares) | -$185.32 | -$768.61 | -$171.34 | -$74.62 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$19.41 | -$20.67 | -$30.29 | |
| Operating activities | ||||
| Depreciation | $1.4 | $1.43 | $1.45 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $7.27 | $8.07 | $6.22 | |
| Total cash flows from operations | -$6.67 | -$3.87 | -$20.69 | |
| Investing activities | ||||
| Capital expenditures | -$1.87 | -$1.96 | -$0.08 | |
| Investments | -$23.22 | $62.59 | $53.32 | |
| Total cash flows from investing | $47.28 | -$25.08 | $60.62 | $53.24 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.1 | $0.62 | $0.25 | |
| Net borrowings | -$144.5 | -$85.06 | ||
| Total cash flows from financing | -$14.74 | -$7.32 | -$3.19 | -$86.12 |
| Effect of exchange rate | -$0.01 | -$0 | -$0 | -$0.02 |
| Change in cash and equivalents | $24.08 | -$39.07 | $53.56 | -$53.6 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$178.69 | -$720.17 | -$169.91 | -$74.62 |
| Operating activities | ||||
| Depreciation | $5.76 | $14.42 | $13.81 | $6.35 |
| Business acquisitions & disposals | -$400.01 | |||
| Stock-based compensation | $46.02 | $109.7 | $70.84 | $10.12 |
| Total cash flows from operations | -$127.62 | -$190.42 | -$127.5 | -$65.01 |
| Investing activities | ||||
| Capital expenditures | -$0.59 | -$2.07 | -$1.89 | -$1.31 |
| Investments | $127.89 | $101.5 | -$232.01 | -$6.59 |
| Total cash flows from investing | $127.31 | $99.43 | -$633.91 | -$7.92 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.27 | $2.22 | $392.03 | $14.51 |
| Net borrowings | -$85.06 | $221.67 | ||
| Total cash flows from financing | -$90.96 | $2.22 | $933.57 | $90.76 |
| Effect of exchange rate | -$0.03 | -$0.12 | -$0.01 | |
| Change in cash and equivalents | -$91.3 | -$88.88 | $172.15 | $17.83 |
News
Fundamentals
| Market cap | $800.91M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 255.88M |
| Revenue | $156.72M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$78.61M |
| Revenue Q/Q | 11.32% |
| Revenue Y/Y | -4.17% |
| P/E ratio | -10.19 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 5.11 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 0.22 |
| EPS | -$0.31 |
|---|---|
| ROA | -40.35% |
| ROE | N/A |
| Debt/Equity | -9.31 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.24 |
| Quick ratio | N/A |